About Affector

Affector is an editorial publication about pharmaceuticals, medicine, biology and life sciences, as well as about software, its architecture, AI and cloud. Two beats, one team.

Our mission

Affector is an editorial publication run by Codeenable, a software studio. We publish two parallel beats: one on pharmaceuticals, medicine, biology and life sciences; one on software, its architecture, AI and cloud. We chose this combination on purpose, not by accident.

The bridge is honest and grounded in practice. Codeenable's founder has long-standing professional experience in both software engineering and the pharmaceutical industry, and that directly shapes our editorial approach. Not everyone on the team is a clinician, and we do not pretend to be, but we read the papers, talk to practitioners and work with people with the right credentials whenever a piece touches health.

Where the two beats overlap (AI in drug discovery, machine learning in diagnostics, digital biomarkers, clinical data infrastructure), our most distinctive writing often lives. A piece on a diagnostic model gets the architecture right and the clinical workflow right. A piece on a discovery platform explains both the chemistry and the data pipeline.

What we will not do: chase hype, run sponsored content disguised as journalism, or treat health topics casually. Decisions about your health belong with a qualified clinician, never with us.

Affector in practice

Affector plays two roles: an editorial team that writes at the boundary of medicine and software, and a software studio that brings that boundary to life in real client work.

Editorial standards

Editorial care for health topics

We do not have practising clinicians on the team and we do not pretend to. Health-touching content rests on peer-reviewed literature, primary sources and the work of recognised authorities. Codeenable's founder's professional experience in the pharmaceutical industry brings a practical lens to pieces that touch pharmacology.

Corrections and last-reviewed dates

Every clinical-topic article carries a "last reviewed" date. We re-review periodically and on substantive change. Corrections are made openly and dated; we do not silently rewrite history.

Sources and citations

We cite peer-reviewed literature and primary sources where they exist, and we link to them. When something is preliminary, preprint or industry-funded, we say so.

Read the full mission

In today's flood of fragmentary information, half-truths, moderated opinions and outright lies, readers find it increasingly hard to reach reliable content, analyses and solid data.

Paradoxically, the internet's unlimited access to information leads to deepening disinformation and often makes it significantly harder to assess reality correctly.

Browsing today's news outlets, it is easy to get the impression that every article was written to order, that its purpose is manipulation or simply nudging the reader toward a specific action.

We never create clickbait, fake news or commercial posts to drive sales or to influence the reader's judgment and behaviour.

We do not publish opinions - we value facts alone and base our analyses and articles on them.

When preparing our publications, we make every effort to ensure that the content we cite is verified and substantively accurate. We make sure it is backed by external sources and analyses, by research from established institutions, independent centres or simply authorities in the given field.

We do not create ads, hidden advertising or marketing campaigns. We play clean. If our content references our own products or services, we mark it clearly.

Even so, we encourage the Reader to independently verify the information that reaches them and to pursue the truth at all costs, in our increasingly computerised world.

Publisher information

Have a question, a story idea or a correction? Get in touch

Affector writes about pharmaceuticals, medicine, biology and the life and human sciences, and also about the technical underpinnings that make these fields advance.

We publish across domains that touch both the core subjects, pharma and medicine, and the technical craft that supports them - software, its architecture, and the current dominance of cloud solutions and AI.

Both silos genuinely interest our team, and the need to integrate digital techniques into medicine, pharma and the human sciences is growing at an avalanche pace.

Without cooperation with software teams, real progress in medicine and pharma is hard to come by today, and the most ambitious engineering projects increasingly emerge in response to real problems in biology and the clinic.

Hence the long-form, sourced writing that does not flinch at code or at clinical detail, producing a unique combination that is genuinely useful to clinicians and engineers alike.